Myron Schwartz
Appearances
- DateMay 8, 2023Transplantation of hepatitis C (HCV) positive lungs has been shown to be a safe means of combating organ shortages in the era of direct-acting antivirals against HCV…
Presenters
Speakers
Mayo Foundation for Medical Education and Research - DateMay 21, 2024BACKGROUND: With the recent increase in metabolic liver diseases and viral hepatitis on anti-viral agents, risk stratification biomarkers are urgently needed to identify cirrhosis patients who should be prioritized for hepatocellular carcinoma (HCC) screening for early detection…
Presenter
Speakers
University of MichiganMayo Foundation for Medical Education and ResearchBaylor College of MedicineBaylor University Medical CenterMichael E. DeBakey VAMCBaylor College of MedicineUT Southwestern Medical CenterUniversity of Texas Southwestern Medical Center
